International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2022   Volume 12   Issue 1

Impact of Patient Education on Quality of Life in Gastroesophageal Reflux Disease
Download PDF


, , , , , ,
Citation
Vancouver
Jallepalli VR, Thalla S, Gavini SB, Tella JD, Kanneganti S, Yemineni G, et al. Impact of Patient Education on Quality of Life in Gastroesophageal Reflux Disease. Int J Pharm Phytopharmacol Res. 2022;12(1):25-8. https://doi.org/10.51847/dAJecTWofD
APA
Jallepalli, V. R., Thalla, S., Gavini, S. B., Tella, J. D., Kanneganti, S., Yemineni, G., & Nadendla, R. R. (2022). Impact of Patient Education on Quality of Life in Gastroesophageal Reflux Disease. International Journal of Pharmaceutical And Phytopharmacological Research, 12(1), 25-28. https://doi.org/10.51847/dAJecTWofD
Download citation:   EndNote   RIS
Article Link:
Downloads: 162
Views: 1831
Abstract

The research pays more attention on evaluating the impact of patient education as directed by a clinical pharmacist concerning the disease, useful effects of treatment, causes of the disease, life style modifications and finally improving quality of life of patients diagnosed with Gastroesophageal reflux disease (GERD). It is a prospective observational study, GSRS scores according to baseline, follow up1 and follow up2 were 7.552 ± 3.63, 3.724 ± 3.39 and 1.414 ± 2.95 in mild (GERD A) patients. In moderate patient, scores were 11.042 ± 3.52, 5.792 ± 2.54 and 1.917 ± 3.01, in severe 10.154 ± 3.955, 6.462 ± 3.71 and 3.00 ± 4.51. HRQL scores of mild (GERD A) patient were 26.069± 12.77, 16.139± 12.19 and 8.138 ± 13.82 according to baseline, follow up1 and follow up2. Similarly moderate (GERD B) patient scores were 30.33±8.61, 17.918 ± 7.51 and 7.583 ± 8.40. Severe (GERD C) scores were 35.846 ± 12.07, 22.308 ± 8.17 and 8.923 ± 7.51. The significant reduction in GSRS scores shows developments in health related quality of life (HRQL) of GERD affected individuals. According to the results of this study, it shows that patient education can effectively reduce symptoms and improve the QOL of GERD patients.

Volume 15
Issue 1
2025

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2024 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.